Ethyl chloroacetate → HCID 24823447, compound
Reaction equation
[CH3:1][O:2][C:3]1[CH:4]=[C:5]2[C:10](=[CH:11][CH:12]=1)[CH2:9][NH:8][CH2:7][CH2:6]2.Cl[CH2:14][C:15]([O:17][CH2:18][CH3:19])=[O:16].C([O-])([O-])=O.[K+].[K+]>CC#N>[CH3:1][O:2][C:3]1[CH:4]=[C:5]2[C:10](=[CH:11][CH:12]=1)[CH2:9][N:8]([CH2:14][C:15]([O:17][CH2:18][CH3:19])=[O:16])[CH2:7][CH2:6]2Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of 6-methoxy-1,2,3,4-tetrahydroisoquinoline, Sall and Grunewald, J. Med. Chem. 1987, 30, 2208-2216 (1.1 mmol), ethyl chloroacetate (1.17 mmol), and K2CO3 (1.17 mmol) in CH3CN (10 mL) is stirred for 18 h. The mixture is partitioned between EtOAc and H2O. The organic phase is concentrated to an oil, which is purified by chromatography (silica gel, gradient, 20-80% EtOAc/hexane) to afford the title compound.
Workup
- customThe mixture is partitioned between EtOAc and H2O
- concentrationThe organic phase is concentrated to an oil, which
- customis purified by chromatography (silica gel, gradient, 20-80% EtOAc/hexane)
Sources & evidence
- ORD record
- ord-df87d5cf47fe414eb289fc72d71208b1
- Source dataset
- uspto-grants-2000_12
- Patent number
- US06159964
Reaction notes
Loading…